ArticleCureus2026
Squamous Cell Carcinoma Arising From Mature Cystic Teratoma in a 39-Year-Old Woman: A Case Report.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Ovarian carcinomas represent the second most common malignancy of the female genital tract; however, primary squamous cell carcinoma (SCC) is a rare subtype. Most of these tumors arise from malignant transformation of mature cystic teratoma (MCT), whereas others are associated with endometriosis or Brenner tumor. Preoperative diagnosis remains challenging because both clinical presentation and imaging findings are frequently nonspecific. Patients often present with symptoms related to the mass effect of the lesion, and metastatic disease may be present at the time of diagnosis. While pelvic ultrasonography and magnetic resonance imaging (MRI) are essential diagnostic adjuncts, histopathological examination remains the gold standard for establishing the diagnosis and guiding management. Current therapeutic strategies necessitate a multimodal approach, including surgical debulking and adjuvant chemotherapy or radiotherapy. We present the case of a 39-year-old woman diagnosed with ovarian SCC arising from a mature cystic teratoma, detailing her clinical presentation and subsequent management. This case highlights the diagnostic and therapeutic challenges associated with malignant transformation of MCTs, particularly in younger patients.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.